WASHINGTON (AP) -- The Supreme Court on Tuesday made it easier for companies to challenge patents, ruling in favor of MedImmune Inc., a biotech firm that makes a childhood respiratory drug. The 8-1 decision in the dispute between MedImmune and Genentech Inc. comes amid a debate in the business world and in government over whether patents are granted too often and are impeding rather than spurring inventions.
